FSN E-Commerce Ventures Limited (BOM:543384)

Inozyme Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	578,041	512,035	462,527	354,417	801,024	-
Market Cap Growth	10.70%	10.70%	30.50%	-55.75%	-	-
Enterprise Value	588,737	523,438	470,912	359,414	804,609	-
Last Close Price	202.05	179.05	161.90	123.10	281.48	-
PE Ratio	874.76	774.87	1433.75	1839.98	1950.15	-
PS Ratio	7.27	6.44	7.24	6.89	21.23	-
PB Ratio	43.05	38.14	36.11	25.46	59.53	-
P/TBV Ratio	53.23	47.15	41.60	29.09	65.42	-
P/FCF Ratio	170.31	150.86	-	-	-	-
P/OCF Ratio	123.88	109.73	185010.75	-	-	-
EV/Sales Ratio	7.41	6.58	7.38	6.99	21.32	-
EV/EBITDA Ratio	131.83	176.50	234.99	261.08	840.63	-
EV/EBIT Ratio	285.96	252.25	386.28	434.14	1203.69	-
EV/FCF Ratio	173.46	154.22	-	-	-	-
Debt / Equity Ratio	0.98	0.98	0.76	0.57	0.44	0.68
Debt / EBITDA Ratio	2.95	2.95	2.94	3.26	3.87	2.36
Debt / FCF Ratio	3.89	3.89	-	-	-	3.65
Asset Turnover	2.15	2.15	2.01	1.84	1.91	2.01
Inventory Turnover	3.43	3.43	3.32	3.05	3.10	3.16
Quick Ratio	0.32	0.32	0.34	0.47	0.87	0.54
Current Ratio	1.24	1.24	1.22	1.59	2.00	1.39
Return on Equity (ROE)	5.49%	5.49%	2.97%	1.53%	4.50%	15.15%
Return on Assets (ROA)	3.52%	3.52%	2.40%	1.85%	2.12%	4.38%
Return on Capital (ROIC)	5.28%	5.28%	3.43%	2.51%	3.03%	6.82%
Return on Capital Employed (ROCE)	11.40%	11.40%	8.00%	4.70%	4.00%	14.00%
Earnings Yield	0.11%	0.13%	0.07%	0.05%	0.05%	-
FCF Yield	0.59%	0.66%	-0.24%	-0.98%	-0.56%	-
Buyback Yield / Dilution	-0.09%	-0.09%	0.05%	-1.24%	-1.73%	-8.12%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.